APLS vs INTU · rev $1.00B vs P/E 64, rev $18.83B
Apellis Pharmaceuticals Inc (APLS) versus Intuit Inc (INTU) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Intuit Inc (INTU) is a software - application company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
APLS currently screens at market cap $2.29B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Not investment advice. Open the APLS and INTU stock pages for the full models.
Not investment advice.